Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jason_ARGONAUTE
    Member
    • Aug 2013
    • 14

    #1

    DESeq NB test for samples without biological replicates

    Hi guys,

    I hv encountered problems performing negative binomial test for samples without replicates while control group has replicates with DESeq.

    Experimental design:
    conduct the experiment under three conditions with common control: A B C (same samples treated at 3 distinct levels -- 50%, 80%, 95%)
    Condition A has two biological replicates, Condition B and C have no biological replicates, Control group has two biological replicates.
    noted as A_1, A_2, B, C, Ctrl_1, Ctrl_2
    Pipeline of transcriptomic RNA-seq(paired-end):
    map clean reads to ref genome using Tophat -> get the raw counts using SAMtools and HTSeq -> normalized the raw counts matrix using DESeq -> negative binomial test using DESeq

    # Do stats based on a negative binomial distribution from Simon's vignette
    With replicates:
    cds = estimateDispersions(cds)
    results = nbinomTest(cds, "condition", "control")
    Without replicates:
    cds = estimateDispersions(cds, method = "blind")
    results = nbinomTest(cds, "condition", "control")

    So, my confusion goes for a reasonable strategy to conduct NB test without replicates:
    I have two replicates of control group(Ctrl1,Ctrl2) while no replicates for conditon B and conditon C, which way to perform a negative binomial test fits best for this case?
    My current strategy is performing NB test between Ctrl1 and B/C(ignore Ctrl2).
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    You'll be better off using the control replicates than if you were to use the "blind" method.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-13-2026, 12:22 PM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-11-2026, 10:35 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    51 views
    0 reactions
    Last Post SEQadmin2  
    Working...